FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Bristol-Myers

Sort
E.g., 2013-05-22
E.g., 2013-05-22
Enter a comma separated list of user names.

*** The U.S. Food and Drug Administration (FDA) has approved Pfizer's (PFE) XALKORI capsules, the first-ever therapy targeting anaplastic lymphoma kinase (ALK), for the treatment of patients with locally advanced or metastatic non-small cell lung cancer that is ALK-positive as detected by an FDA-approved test.

*******************************

As the world’s foremost imaging innovator, EK helps consumers, businesses, and creative professionals unleash the power of pictures and printing to enrich their lives

EK announced Last January that it filed lawsuits against Apple Inc. and Research In Motion Limited (RIM) alleging the infringement of Kodak digital imaging technology.

Power3 Medical Products, Inc. (OTC.BB:PWRM) is discovering proteins and protein patterns associated with many diseases including, but not limited to, prostate cancer, breast cancer, Alzheimer's disease, ALS (Lou Gehrig's disease), Parkinson's disease, and gastrointestinal disease.

Pfocus on Pfizer

Posted by ockhamsrazor on August 27th, 2008

For shareholders of Pfizer, Inc. (PFE) stock, it has been a pretty barren decade. No investor can look at Pfizer’s ten year chart and miss the fact that the stock has been a multi-year dog. However, from a valuation standpoint, these high-yielding shares are worthy of consideration for patient, income-oriented investors.

ADVERTISE WITH US